Lotus Pharmaceutical Correlations
The current 90-days correlation between Lotus Pharmaceutical and Chung Hsin Electric Machinery is -0.12 (i.e., Good diversification). The correlation of Lotus Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Lotus Pharmaceutical Correlation With Market
Average diversification
The correlation between Lotus Pharmaceutical Co and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lotus Pharmaceutical Co and DJI in the same portfolio, assuming nothing else is changed.
Lotus |
The ability to find closely correlated positions to Lotus Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lotus Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lotus Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lotus Pharmaceutical Co to buy it.
Moving together with Lotus Stock
| 0.66 | 6674 | Compal Broadband Networks | PairCorr |
| 0.75 | 1591 | Inmax Holding | PairCorr |
| 0.64 | 2345 | Accton Technology Corp | PairCorr |
Moving against Lotus Stock
| 0.78 | 3206 | Kingstate Electronics | PairCorr |
| 0.66 | 4108 | Phytohealth Corp | PairCorr |
| 0.66 | 5215 | Ko Ja Cayman | PairCorr |
| 0.64 | 0051 | YuantaP shares Taiwan | PairCorr |
| 0.62 | 4114 | Synmosa Biopharma | PairCorr |
| 0.61 | 6785 | Alar Pharmaceuticals | PairCorr |
| 0.58 | 6539 | DV Biomed | PairCorr |
| 0.5 | 6620 | Handa Pharmaceuticals | PairCorr |
| 0.43 | 3556 | eGalaxeMPIA Technology | PairCorr |
| 0.35 | 4702 | Allied Industrial | PairCorr |
Related Correlations Analysis
| 0.68 | 0.46 | 0.72 | -0.35 | 1513 | ||
| 0.68 | 0.08 | 0.88 | -0.31 | 8046 | ||
| 0.46 | 0.08 | -0.02 | -0.05 | 1760 | ||
| 0.72 | 0.88 | -0.02 | -0.4 | 4142 | ||
| -0.35 | -0.31 | -0.05 | -0.4 | 3443 | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Lotus Stock performing well and Lotus Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lotus Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 1513 | 1.50 | (0.03) | (0.04) | 0.05 | 1.61 | 3.35 | 9.27 | |||
| 8046 | 1.70 | (0.20) | 0.00 | (0.32) | 0.00 | 3.66 | 11.88 | |||
| 1760 | 0.90 | (0.06) | 0.00 | (0.26) | 0.00 | 2.25 | 6.62 | |||
| 4142 | 0.86 | (0.40) | 0.00 | 3.61 | 0.00 | 1.42 | 5.67 | |||
| 3443 | 2.34 | 0.42 | 0.14 | 1.07 | 2.11 | 5.51 | 14.31 |
Lotus Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lotus Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Lotus Pharmaceutical could also be used in its relative valuation, which is a method of valuing Lotus Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Lotus Pharmaceutical Corporate Management
Elected by the shareholders, the Lotus Pharmaceutical's board of directors comprises two types of representatives: Lotus Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lotus. The board's role is to monitor Lotus Pharmaceutical's management team and ensure that shareholders' interests are well served. Lotus Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lotus Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Petar Vazharov | GM Director | Profile | |
| Bjartur Shen | VP Fin | Profile | |
| Charles Lin | Strategic Consultant | Profile | |
| Eeling Chan | Chief Officer | Profile | |
| Zenon Zdunek | VP Operations | Profile | |
| Saral Thangam | Chief Services | Profile | |
| Angela Luan | Corp Director | Profile |